Hepatitis C NS3 inhibitors belong to a chemical class designed to specifically target and inhibit the activity of the NS3 protein of the hepatitis C virus (HCV). NS3 is a multifunctional protease responsible for the cleavage of viral polyproteins, an essential step in the viral replication cycle. Inhibiting the NS3 protein impedes the virus from efficiently replicating and producing infectious viral particles.
These inhibitors are crucial tools in the field of virology and antiviral drug discovery, as they provide valuable insights into the molecular mechanisms of HCV replication and offer targets for the development of antiviral therapies. By disrupting the function of NS3, these inhibitors hold promise in combating HCV infections and may contribute to the ongoing efforts to control the spread of this significant human pathogen. However, it is important to note that the applications of NS3 inhibitors are subject to further research and evaluation.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Simeprevir | 923604-59-5 | sc-473928 sc-473928A | 5 mg 50 mg | $296.00 $2040.00 | ||
Simeprevir is an NS3/4A protease inhibitor that prevents the cleavage of the viral polyprotein, inhibiting viral replication. | ||||||
Danoprevir | 850876-88-9 | sc-364480 sc-364480A | 5 mg 50 mg | $320.00 $1950.00 | ||
Danoprevir is a potent NS3 protease inhibitor. | ||||||